The decision to continue, adjust, or discontinue semaglutide should be based on the overall risk-benefit assessment and whether a plausible connection between the medication and back pain can be established through clinical evaluation
Tirzepatide demonstrated remarkable weight-reducing efficacy in randomized controlled trials such as SURMOUNT-1 and SURMOUNT-2, with mean body-weight reductions ranging from 15 to 22.5% (32, 33)
But if you're talking about comparing fish to eating krill, like we're talking about the foods- Andrew Huberman: Oh, I would never eat krill
Framed that way, and screened by a provider first, it earns its place as wellness support rather than as medicine that treats disease
It does important jobs like increasing insulin, slowing down how quickly the stomach empties, and curbing appetite by reducing cravings